OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is a stock that has been one of the more dramatic winners of the Fall trading season, helped along powerfully by its association with the cannabis space. We have been watching stocks in the group launch higher on a daily and weekly basis for the past couple months. OWCP stock has wildly outperformed most of the space during that run, blasting off over 4,600% in the past 5 weeks.
As the reader will no doubt be aware, on Tuesday of this week, citizens of nine different states will take to the ballot boxes to cast their votes on the future legal status of marijuana for either medicinal or recreational use, depending on the state. This stock is well-positioned into that vote.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) bills itself as a company that engages in the research and development of Cannabis-based medical products. The company provides medical products for the treatment of various medical conditions and/or diseases, such as multiple myeloma, psoriasis, PTSD, and migraines; and delivery systems. It also provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations.
OWCP through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals, treatments and unique delivery systems for the effective delivery and dosage of medical cannabis.
All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators.
The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
The Company is a wholly owned subsidiary of OWC Pharmaceutical Research Corp. The company was formerly known as Dynamic Applications Corp. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Petach Tikva, Israel.
Find out when $OWCP stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
The only recent news to hit recently is the company’s announcement last week that it has inked agreement for a combined JV & Private Placement of $300,000 with Michepro Holding Ltd, a private family investment company organized under the laws of the state of Cyprus. The Investor will be issued with 2,307,692 restricted shares of the Company’s common stock (a price of $0.13 per share) with additional warrants to purchase 761,538 restricted shares at an exercise price of $0.25 per share for a period of 24 months, and additional warrants for 761,538 restricted shares at an exercise price of $0.40 per share for a period of 36 months.
As covered in the recent release, “In addition to the investment, the parties will establish a joint venture, 75% to OWCP and 25% to Michepro Holding Ltd to promote, sell, market and distribute the Company’s potential products in Europe, initially with the psoriasis treatment, to be followed with company’s other therapies as they become available.” The World Health Organization’s 2016 Global Report on Psoriasis states that psoriasis is a serious global problem affecting at least 100 million individuals worldwide.”
The report indicates that “the prevalence of psoriasis ranges from 0.09% in countries with warmer climates to 11.43% in Norway, where a colder climate prevails. The European market for psoriasis is estimated to be 15-20 Million patients.” Mr. Mordechai Bignitz, OWCP’s Chairman and CEO, commented on the announcement, “We are excited to partner with Michepro Holding Ltd. The investment proceeds will be used to accelerate development of several of OWCP’s products and support international marketing activities”.
Mr. Bignitz went on to say: “the recent activity in OWCP stock has given rise to numerous investment proposals, but after reviewing the options we believe that Michepro Holding Ltd represents the best opportunity for the Company and our shareholders. Their EU business development experience and marketing expertise, as well as their enthusiasm about our future as a company are very encouraging, and it is the perfect follow-up to the agreement with signed with MedMar for the US.”
Earning a current market cap value of $18.2M, OWCP has a decent store ($162.28k) of cash on the books, in a pool of total assets exceeding $200K, which must be weighed relative to virtually no total accumulated debt. Traders will note just shy of 150% during the past month in terms of shareholder gains in the stock.
Market participants may want to continue to pay close attention to this stock given the overwhelming surge in interest into the vote this week. OWCP stock has registered increased average transaction volume recently, with the past month seeing over 10,000% beyond its prior sustained average level. We will update the story again as events dictate. For continuing coverage on shares of OWCP stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!